Clinical trial
Efficacy of Oral Melatonin Versus Oral Tranexamic Acid in the Management of Melasma
NCT07169383 is registered in ClinicalTrials.gov with Hina Malik as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Oral Melatonin Versus Oral Tranexamic Acid in the Management of Melasma
- Lead sponsor
- Hina Malik
- Phase
- Phase 2
- Overall status
- Enrolling by invitation
- Start date
- June 28, 2025
- Completion date
- December 28, 2025
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melasma (facial melasma)